Acteoside inhibits the progression of squamous cell carcinoma by regulating the TWEAK/cIAP1/NF-κB signaling axis and secretion of IL-6, IL-8 and VEGF
{{output}}
Background: The global incidence of squamous cell carcinoma (SCC) is on the rise. Previous studies have confirmed that the TWEAK/cIAP1/NF-κB axis plays a crucial role in SCC progression. Acteoside (ACT), a phenylethanoid glycosi... ...
